Quing Zhu joined Washington University in St. Louis as a professor of the Department of Biomedical Engineering in July 2016. Previously, she was a professor of Electrical and Computer Engineering and Biomedical Engineering at the University of Connecticut. Professor Zhu is a leading researcher in combining ultrasound and NIR imaging modalities for clinical diagnosis of breast cancers. This combined approach offers the following advantages: a) ultrasound localization overcomes the localization uncertainty of optical reconstruction, and b) the use of high cancer-to-tissue optical contrast improves the ultrasound diagnosis. She and her team have explored the theory and modeling behind this novel technique and have conducted clinical studies at the UConn Health Center and Hartford Hospital, CT. Initial results have shown success in early diagnosis of malignant and benign breast lesions using this technique. Professor Zhu has also extended this technology to predict and monitor the neoadjuvant chemotherapy responses of advanced breast cancers. The studies were selected as platform presentations of the 2007 and 2008 San Antonio Breast Cancer Symposiums and highlighted in the Symposium News Letters. The study has received publicity in news releases of the Radiological Society of North America, the prestigious Society of Radiology and Imaging in 2005 and 2010. In addition, Professor Zhu and her team have pioneered co-registered photoacoustic and ultrasound imaging system and device developments for ovarian cancer detection. The Pilot studies have shown great potential of the technique in improving ovarian cancer diagnosis. She and her team have also made important contributions using optical coherent tomography, spatially modulated light, and photoacoustic techniques to image and characterize ovarian tissues for potential early detection diagnosis of ovarian cancers.